Role of the NMDA receptor GluN2D subunit in the expression of ketamine-induced behavioral sensitization and region-specific activation of neuronal nitric oxide synthase

Neuroscience Letters

Volumn 610, Issue , 2016, Pages 48-53

  Yamamoto, Toshifumi ^a   Nakayama, Tomomi ^a   Yamaguchi, Junji ^a   Matsuzawa, Maaya ^a   Mishina, Masayoshi ^b   Ikeda, Kazutaka ^c   Yamamoto, Hideko ^c  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b RITSUMEIKAN UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

GluN2D; Ketamine; Knockout; Neuronal nitric oxide synthase; Sensitization

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEURONAL NITRIC OXIDE SYNTHASE; NICOTINAMIDE ADENINE DINUCLEOTIDE NUCLEOSIDASE; NITRIC OXIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NR2D NMDA RECEPTOR; PROTEIN SUBUNIT; PSYCHOTROPIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DENDRITE; ENZYME ACTIVATION; HISTOCHEMISTRY; LOCOMOTION; MALE; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; C57BL MOUSE; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOTOR ACTIVITY; NERVE CELL; PROTEIN SUBUNIT;

ANIMALS; CORPUS STRIATUM; ENZYME ACTIVATION; KETAMINE; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NADP; NEURONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; ORGAN SPECIFICITY; PREFRONTAL CORTEX; PROTEIN SUBUNITS; PSYCHOTROPIC DRUGS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84946397972     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2015.10.049     Document Type: Article

References (24)

1. Abekawa T., Ohmori T., Koyama T. Effects of nitric oxide (NO) synthesis inhibition on the development of supersensitivity to stereotypy and locomotion stimulating effects of methamphetamine. Brain Res. 1995, 679:200-204.
2. Bredt D.S., Hwang P.M., Glatt C.E., Lowenstein C., Reed R.R., Snyder S.H. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991, 351:714-718.
3. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. U. S. A. 1990, 87.
4. Chatterjee M., Verma R., Ganguly S., Palit G. Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in mice. Neuropharmacology 2012, 63:1161-1171.
5. Christopherson K.S., Hillier B.J., Lim W.A., Bredt D.S. PSD-95 assembles a ternary complex with the N-methyl-d-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J. Biol. Chem. 1999, 274:27467-27473.
6. Dawson T.M., Bredt D.S., Fotuhi M., Hwang P.M., Snyder S.H. Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:7797-7801.
7. Encinas J.M., Fernandez A.P., Salas E., Castro-Blanco S., Munoz P., Rodrigo J., Serrano J. Nitric oxide synthase and NADPH-diaphorase after acute hypobaric hypoxia in the rat caudate putamen. Exp. Neurol. 2004, 186:33-45.
8. Franklin K., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 2007, Academic Press/Elsevier, Amsterdam.
9. Hagino Y., Kasai S., Han W., Yamamoto H., Nabeshima T., Mishina M., Ikeda K. Essential role of NMDA receptor channel epsilon4 subunit (GluN2D) in the effects of phencyclidine, but not methamphetamine. PloS one 2010, 5:e13722.
10. Haracz J.L., MacDonall J.S., Sircar R. Effects of nitric oxide synthase inhibitors on cocaine sensitization. Brain Res. 1997, 746:183-189.
11. Hoque K.E., West A.R. Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens. Synapse 2012, 66:220-231.
12. Ikeda K., Araki K., Takayama C., Inoue Y., Yagi T., Aizawa S., Mishina M. Reduced spontaneous activity of mice defective in the epsilon 4 subunit of the NMDA receptor channel. Mol. Brain Res. 1995, 33:61-71.
13. Inoue H., Arai I., Shibata S., Watanabe S. NG-nitro-l-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitization and enhancement of striatal dopamine release. J. Pharmacol. Exp. Ther. 1996, 277:1424-1430.
14. Karler R., Calder L.D., Thai L.H., Bedingfield J.B. A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine. Brain Res. 1994, 658:8-14.
15. Kim S.Y., Lee H., Kim H.J., Bang E., Lee S.H., Lee D.W., Woo D.C., Choi C.B., Hong K.S., Lee C., Choe B.Y. In vivo and ex vivo evidence for ketamine-induced hyperglutamatergic activity in the cerebral cortex of the rat: potential relevance to schizophrenia. NMR Biomed. 2011, 24:1235-1242.
16. 2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine. J. Neurosci. 2009, 29:2774-2779.
17. Moghaddam B., Adams B., Verma A., Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J. Neurosci. 1997, 17:2921-2927.
18. Pudiak C.M., Bozarth M.A. L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine. Life Sci. 1993, 53:1517-1524.
19. Stone J.M., Dietrich C., Edden R., Mehta M.A., De Simoni S., Reed L.J., Krystal J.H., Nutt D., Barker G.J. Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology. Mol. Psychiatry 2012, 17:664-665.
20. Trujillo K.A., Zamora J.J., Warmoth K.P. Increased response to ketamine following treatment at long intervals: implications for intermittent use. Biol. Psychiatry 2008, 63:178-183.
21. Watanabe M., Inoue Y., Sakimura K., Mishina M. Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Neuroreport 1992, 3:1138-1140.
22. West A.R., Grace A.A. The nitric oxide-guanylyl cyclase signaling pathway modulates membrane activity States and electrophysiological properties of striatal medium spiny neurons recorded in vivo. J. Neurosci. 2004, 24:1924-1935.
23. West A.R., Grace A.A. Striatal nitric oxide signaling regulates the neuronal activity of midbrain dopamine neurons in vivo. J. Neurophysiol. 2000, 83:1796-1808.
24. Yamamoto H., Kamegaya E., Sawada W., Hasegawa R., Yamamoto T., Hagino Y., Takamatsu Y., Imai K., Koga H., Mishina M., Ikeda K. Involvement of the N-methyl-d-aspartate receptor GluN2D subunit in phencyclidine-induced motor impairment, gene expression, and increased Fos immunoreactivity. Mol. Brain 2013, 6:56.